Lübbert Christoph, Lippmann Norman, Busch Thilo, Kaisers Udo X, Ducomble Tanja, Eckmanns Tim, Rodloff Arne C
Division of Infectious Diseases and Tropical Medicine, Department of Gastroenterology and Rheumatology, Leipzig University Hospital, Leipzig, Germany.
Institute for Medical Microbiology and Epidemiology of Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Hospital Hygiene Staff Unit, Leipzig University Hospital, Leipzig, Germany.
Am J Infect Control. 2014 Apr;42(4):376-80. doi: 10.1016/j.ajic.2013.12.001.
The natural progress of intestinal colonization with Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae (KPC-2-KP) is almost unknown.
After a large, single-center outbreak of KPC-2-KP, we analyzed carrier prevalence through retrospective and prospective investigation of intestinal KPC-2-KP carriage 1 month, 3 months, 6 months, 1 year, and 2 years after acquisition, defined as the earliest date of KPC-2-KP detection. Rectal swabs or stool samples were collected at baseline and at each visit and submitted for both culture and KPC-specific polymerase chain reaction. Resolution of intestinal KPC-2-KP carriage was defined as a minimum of 3 consecutive negative polymerase chain reaction test results separated by at least 48 hours.
In patients available for long-term evaluation 26 out of 84 patients (31%) tested negative for KPC-2-KP after 1 month, 14 out of 34 (41%) after 3 months, 17 out of 26 (65%) after 6 months, 14 out of 19 (74%) after 1 year, and 5 out of 6 (83%) after 2 years. Decolonization of KPC-2-KP was hampered in patients with prolonged or repeated hospitalization (P = .044-.140, depending on the time interval). Two patients retested positive for KPC-2-KP after they had previously shown 3 consecutive negative tests. The longest positive KPC-2-KP carrier status so far was observed after nearly 40 months (1,191 days).
The majority of patients experienced spontaneous decolonization within 6 months after acquisition, mainly after discharge from the hospital. However, long-term carriage of >3 years is possible. Appropriate infection control measures must be taken when these patients are readmitted to health care facilities. A series of at least 4 consecutive negative rectal swabs or stool samples separated by sufficient time intervals appears necessary before the declaration of successful KPC-2-KP decolonization is made.
携带产肺炎克雷伯菌碳青霉烯酶-2(KPC-2)的肺炎克雷伯菌(KPC-2-KP)在肠道内定植的自然发展过程几乎不为人知。
在一次大型单中心KPC-2-KP暴发后,我们通过回顾性和前瞻性调查分析了在获得感染(定义为最早检测到KPC-2-KP的日期)后1个月、3个月、6个月、1年和2年时肠道KPC-2-KP携带情况的携带者患病率。在基线和每次随访时收集直肠拭子或粪便样本,并进行培养和KPC特异性聚合酶链反应检测。肠道KPC-2-KP携带的清除定义为至少3次连续的阴性聚合酶链反应检测结果,且每次检测间隔至少48小时。
在可进行长期评估的患者中,84例患者中有26例(31%)在1个月后KPC-2-KP检测呈阴性,34例中有14例(41%)在3个月后呈阴性,26例中有17例(65%)在6个月后呈阴性,19例中有14例(74%)在1年后呈阴性,6例中有5例(83%)在2年后呈阴性。住院时间延长或反复住院的患者中,KPC-2-KP的去定植受到阻碍(P = 0.044 - 0.140,取决于时间间隔)。两名患者在先前显示3次连续阴性检测后,再次检测KPC-2-KP呈阳性。迄今为止,观察到的最长KPC-2-KP阳性携带者状态持续了近40个月(1191天)。
大多数患者在获得感染后的6个月内,主要是在出院后,经历了自发去定植。然而,携带超过3年也是可能的。当这些患者再次入住医疗机构时,必须采取适当的感染控制措施。在宣布成功清除KPC-2-KP之前,似乎需要一系列至少4次连续的阴性直肠拭子或粪便样本,且样本采集有足够的时间间隔。